7000 SHORELINE COURT, SUITE 350, SOUTH SAN FRANCISCO, CA
Material disclosure
Other Events
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Business Update
IDEAYA Biosciences Files New Automatic Shelf Registration Statement
Annual Report to Security Holders
Q1
FY 2024
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence